SOLS

LONGCONGRESS SELL

Solstice Advanced Matls Inc

Research: Finviz ↗·Perplexity ↗

🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.

Funds

Score

2.63

vs SPY

-37.4%

Stock return (since Q-end)

-17.7%

SPY return (since Q-end)

+19.7%

Current price

$62.65

Days to cover (short int.)

3.3d↑+12.1%

as of 2026-07-31

News Summary

Positive

Solstice delivered strong Q1 and Q2 2026 results with revenue and earnings beats, raising full-year guidance amid robust demand from AI, semiconductors, and nuclear sectors. The company announced a transformational $14.5B acquisition of Element Solutions to create a $6.8B specialty chemicals leader, though this significantly increased leverage and prompted multiple analyst price target cuts.

Red flags

•Q1 net income declined 37% year-over-year ($85M vs $134M) despite 10% revenue growth, signaling margin compression
•Adjusted EBITDA margin compressed to 25.1% in Q1 from 27.9% YoY due to product mix, standalone costs, and R&D increases
•Element Solutions acquisition materially increases leverage; company depends on debt financing in uncertain macro environment and successful synergy realization
•Multiple analyst price target cuts following acquisition announcement (BMO $101→$90, Mizuho $95→$70, RBC $102→$82), suggesting investor concern about valuation and execution risk
•Deal closing contingent on shareholder and regulatory approvals with execution risk through H1 2027

Funds Buying (3)

Fund	Manager	Shares Held	∆ Shares	Position Value	% of Fund	QoQ	Status
Coatue Management	Philippe Laffont	1.7M	+1.7M	$126M	0.4%	—	NEW
Point72	Steve Cohen	1.2M	+1.2M	$94M	0.2%	—	NEW
Duquesne Family Office	Stanley Druckenmiller	63K	+63K	$5M	0.2%	—	NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where SOLS ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Coatue Management

position #32 of this fund's book

29MASTEC INC$188M
30QUALCOMM INC$179M
31CARIS LIFE SCIENCES INC$176M
32SOLSTICE ADVANCED MATLS INC$126M
33C H ROBINSON WORLDWIDE IN$95M
34SPROUTS FMRS MKT INC$93M
35DOORDASH INC$83M

Values are quarter-end position sizes. Shown only for funds where SOLS ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Beneficial Ownership (13D/13G)

Filer	Form	Shares	% of Class	Filed	Src
The Vanguard Group	SC 13G/A	18.4M	11.6%	2026-01-30	↗
BlackRock, Inc.	SC 13G	16.5M	10.4%	2026-01-08	↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

Member	Chamber	State	Type	Amount Range	Transaction Date	Filed	Src
Alan Armstrong	senate	—	SELL	$1,001 - $15,000	2026-03-24	2026-07-21	↗

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.